Dr. Mei Chen Professor of Research Department of Dermatology Other publications: 1. Flomenberg PR, Chen M, Horwitz MS: Characterization of MHC class I antigenbinding glycoprotein from adenovirus 35, a type associated with immunocompromised hosts. J. Virol. 61:3665-3671, 1987. 2. Flomenberg PR, Chen M, Horwitz MS: The molecular epidemiology of adenovirus type 35 isolated from immunocomprosed hosts. J. infec. Dis. 155:1127-1134, 1987. 3. Flomenberg PR, Chen M, Horwitz MS: Sequence and genetic organization of the adenovirus type 35 early region 3. J. Virol. 62:4431-4437, 1988. 4. Chen M, Horwitz MS: Dissection of functional domains of adenovirus DNA polymerase by linker insertion mutagenesis. Proc. Natl. Acad. Sci. USA 86:6116-6120, 1989. 5. Chen M, Mermod N, Horwitz MS: Protein-protein interaction between adenovirus DNA polymerase and nuclear factor I mediate formation of the DNA replication preinitiation complex. J. Biol. Chem. 265:18634-18642, 1990. 6. Chen M, Horwitz MS: Replication of adenovirus type 34 mutant DNA containing tandem reiterations of inverted terminal repeat. Virol. 179:567-575, 1990. 7. Chen M, Horwitz MS: Protein-DNA interactions at the adenovirus origin of replication: eukaryotic DNA polymerases. (Heidelberg: Springer-Verlag) 1991. 8. Chen M, Pan ZQ, Hurwitz J: Sequence and expression in E. coli of the 40-kDa subunit of activator I (replication factor C) of Hela cells: Proc. Natl. Acad. Sci. USA 89:25162520, 1992. 9. Chen M, Pan ZQ, Hurwitz J: Studies of the cloned 37-kDa subunit of activator I (replication factor C) of Hela cells. Proc. Natl. Acad. Sci. USA 89:5211-5215, 1992. 10. Pan ZQ, Chen M, Hurwitz J: The subunits of activator I (replication factor C) carry out multiple functions essential for proliferating-cell nuclear antigen-dependent DNA synthesis. PNAS USA. 90:6-10, 1993. 11. O'Donnell M, Onrust R, Dean FB, Chen M, Hurwitz J: Homology in accessory proteins of replication polymerases E. coli to human. Nuclei Acid Res. 21:1-3, 1993. 12. Ozawa K, Dean B, Chen M, Lee SH, Shiratori A, Murakami Y, Sakakura T, Hurwitz J, Eki T; Mapping of the 70kDa, 34kDa, and 11kDa subunit gene of the human multimeric single-stranded DNA binding protein (hSSB/PRA) to chromosome bands 17p13, 1p35-p36, and 7p21-22. Cell Stru. and Fun. 18:221-230, 1993. 13. Chen M, Achkar C, Gudas LJ: Enzymatic conversion of retinaldehyde to retinoic acid by cloned murine cytosolic and mitochondrial aldehyde dehydrogenases. Mol. Pharmacology 46:88-96, 1994. 14. Okumura K, Nogami M, Taguchi H, Dean FB, Chen M, Pan ZQ, Hurwitz J, Shiratori A, Murmakami Y: Assignment of the 36.5-Kda (RFC5), 38-kDa (RFC3) and 40-kDa (RFC2) subunit genes of human replication factor C to human chromosome bands 12q24, 2-q24.3, 3q27, 13q12, 3-q13 and 7q 11.23 Genomics 25:274-278, 1995. 15. Chen M, Quintans, J, Weichselbaum RR: Suppression of Bcl-2 mRNA production may mediate apoptosis after ionization radiation, TNF, and ceramide. Cancer Res. 55:991-994, 1995. 16. Xu JH, Kim S, Chen M, Wagner A, Hay N, Li W. Growth arrest by IFN-r: blocking CSF-1-and phorbol ester-stimulated MAP kinase activation in the abscence of ISGFactivation. Blood 86:2774-2788, 1995. 17. Chan LS, Chen M, Woodley DT: Epidermolysis bullosa acquisita in the elderly: clinical manifestation, diagnosis, and therapy. J. Geriatr Dermatol. 4:47-52, 1996. 18. Chen M, Petersen PJ, Hai-Li L, Cai X-Y, O’Toole EA, Woodley, DT: Ultraviolet A irradiation up-regulates type VII collagen expression in human dermal fibroblasts. J. Invest. Dermatol. 108:125-128, 1997. 19. Chen M, Goyal S, Cai X-Y, O'Toole EA, Woodley DT: Modulation of type VII collagen (anchoring fibrils) expression by retinoids in human skin cells. Biochim. & Biophys. Acta. 1351:333-340, 1997. 20. Chen M, Marinkovich MP, Veis A, O’Toole EA, Rao CN, Cai X-Y, Woodley DT: Interactions of the amino-terminus noncollagenous domain (NC1) of type VII collagen with extracellular matrix components: A potential role in epidermal-dermal adherence in human skin. J. Biol. Chem. 272:14516-14522, 1997. 21. Chen M, Chan LS, Cai X-Y. O’Toole EA, Sample JC, Woodley DT: Development of an ELISA for rapid detection of anti-type VII collagen autoantibody in EBA. J. Invest. Dermatol. 108:68-72, 1997. 22. Chan LS, Majmudar AA. Tran HH, Schaumburg-Level G. Chen M, Woodley DT, Marinkovich MP: Laminin –6 is a lamina densa autoantigen in oral mucosal pemphigoid. J. Invest. Dermatol. 97:848-853, 1997. 23. She H-Y, Nishimura R, Chen M, Rockow S, Margolis B, Skolink E, Li W: Grb2 links receptor tyrosine kinase to Wiskott-A; drich syndrome protein (WASP). Mol. Biol. Cell 8:1709-1721, 1997. 24. Olivry T, Fine J-T, Dunston SM, Chasse D, Pascal TA, Monteiro-Riviere NA, Chen M, Woodley DT: Canine epidermolysis bullosa acquisita: circulating autoantibodies target the aminoterminal noncollagenous (NC1) domain of collagen VII in anchoring fibrils. Vet. Dermatol. 9:19-31, 1998. 25. Chan LS, Vandelugt CJ, Hashimoto T, Nishikawa T, Zones JJ, Black MM, Wojnarowask F, Stevens SR, Chen M, Fairley JA, Miller SD, Gordon KB: Epitope spreading: lessons from autoimmune skin disease. J. Invest. Deramtol. 110:103-109, 1998. 26. Xu L, Chen M, Peng J, O’Toole EA, Woodley, DT, Chan, LS: Molecular cloning and characterization of a cDNA encoding canine type VII collagen non-collagenous (NC1) domain, the target antigen of autoimmune disease epidermolysis bullosa acquisita (EBA). Biochim & Biophys Acta 1408:25-34, 1998. 27. Chen M, Marinkovich MP, Jones JJ, O’Toole EA, Woodley DT: NC1 domain of type VII collagen binds to the beta 3 chain of laminin 5 via a unique subdomain within the fibronectin-like repeats. J. Invest. Dermatol. 112:177-183, 1999. 28. Chan LS, Lapiere JC, Chen M, Mancini A, Paller A, Woodley DT: Bullous systemic lupus erythematosus with IgG and IgA autoantibodies targeting multiple skin basement membrane zone components. Arch. Dermatol. 135:569-573, 1999. 29. Chen M, O’Toole EA, Li YY, Woodley DT: 21 integrin mediates dermal fibroblast attachment to type VII collagen via a 158 amino acid segment of the NC1 domain. Exp. Cell Res. 249:231-239, 1999. 30. Xu L, O’Toole EA, Olivry T, Hernandez C, Pen J, Chen M, Chan LS: Molecular clonning of a canine bullous pemphigoid antigen 2 cDNA and immunomapping of NC16A domain by canine bullous pemphigoid autoantibodies. Biochim & Biophys Acta 1500:97-107, 1999. 31. Olivry T, Savary KC, Murphy KM, Dunston SM, Chen M: Bullous system lupus erythematosus (type I) in a dog. Vet. Rec. 145:165-169, 1999. 32. Chen M, O’Toole EA, Muellenhoff M, Medina E, Woodley DT: Development and characterization of a recombinant truncated type VII collagen ‘minigene’: implication for gene therapy of dystrophic epidermolysis bullosa. J. Biol. Chem. 275:2442924435, 2000. 33. Gandhi K, Chen M, Aasi S, Lapiere JC, Woodley DT, Chen LS: Autoantibodies to type VII collagen have heterogeneous subclass and light chain composition and their complement activating capacity do not correlate with the inflammatory clinical phenotype. J. Clin. Immuno. 20: 416-423, 2000. 34. Chen M, Keene DR, Costa FK, Tahk SH, Woodley DT: The carboxyl terminus of type VII collagen mediates antiparallel dimer formation and constitutes a new antigenic epitope for epidermolysis bullosa acquisita autoantibodies. J. Biol. Chem. 276:21649-21655, 2001. 35. Li W, Nadelman C, Henry G, Fan JF, Muellenhoff M, Medina E, Gratch NS, Chen M, Han JH, Woodley DT: The p38MAPK/SAPK pathway is required for human keratinocyte migration on dermal collagen. J. Invest. Dermatol. 117:1601-1611, 2001. 36. Hallel-Halevy D, Nadelman C, Chen M, Woodley DT: Epidermolysis bullosa acquisita: update and review. Clin. Dermatol. 19:712-718, 2001. 37. Chen M, Costa FK, Lindvay CR, Han YP, Woodley DT: The recombinant expression of full-length type VII collagen and characterization of molecular mechanisms underlying dystrophic epidermolysis bullosa. J. Biol. Chem. 277:2118-21124, 2002. 38. Chen M, O’Toole EA, Sanghavi J, Mahmud N, Kelleher D, Woodley DT: The EBA antigen (type VII collagen) is present in human colon and patients with Crohn’s disease have autoantibodies to type VII collagen. J. Invest. Dermatol. 118:1059-1064, 2002. 39. Li W, Nadelman C, Gratch NS, Li WQ, Chen M, Kasahara N, Woodley DT: An important role for protein kinase C- in human keratinocyte migration on dermal collagen. Exp. Cell Res. 15:219-228, 2002. 40. Delbaldo C, Chen M, Friedli A, Prins C, Saurat JH, Woodley DT, Borradori L: Druginduced epidermolysis bullosa acquisita with antibodies to type VII collagen. J. Am. Acad. Dermatol. 46:S161-164, 2002. 41. Chen M, Keene DR, Chan LS, Hoeffler WK, Finlay D, Kasahara N, Woodley DT: Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa. Nat. Genet. 32:670-675, 2002. 43. Jean-Baptiste S, O'Toole EA, Chen M, Guitart J, Paller A, Chan LS: Expression of eotaxin, an eosinophil-selective chemokine, parallels eosinophil accumulation in the vesiculobullous stage of incontinentia pigmenti. Clin. Exp. Immunol. 127:470-478, 2002. 44. Schmidt E, Chen M, Kuhn C, Weber L, Brocker EB, Zillikens D: Childhood epidermolysis bullosa acquisita: a novel variant with reactivity to all three structural domains of type VII collagen. Br. J. Dermatol. 147:592-597, 2002. 44. Chen M, Li W, Fan JH, Kasahara N, and Woodley DT: Lentiviral vectors mediate highly efficient and sustained gene transfer in primary human skin cells. Clin. Exp. Dermatol. 28:193-199, 2003. 45. Woodley DT, Krueger GG, Fairley JA, Atha T, Huang Y, Chan L, Keene DR, and Chen M: Normal and gene-corrected dystrophic epidermolysis bullosa fibroblasts alone can produce type VII collagen at the basement membrane zone. J. Invest. Dermatol. 121: 1021-1028, 2003. 46. Li W, Fan J, Chen M, Guan S, Sawcer D, Bokoch GM, Woodley DT: Mechanism of human dermal fibroblast migration driven by type I collagen and PDGF-BB. Mol. Biol. Cell 15:294-309, 2004. 47. Woodley DT, Atha T, Huang Y, Lipman K, Keene DR, Li W, Chen M: Injection of recombinant human type VII collagen restores collagen function in dystrophic epidermolysis bullosa. Nat. Medicine 10:693-695, 2004 48. Li W, Henry G, Fan JF, Sawcer D, Chen M, Pang K, Woodley DT: The initiation, augmentation and directionality signals for human keratinocyte migration. J. Invest. Dermatol. 123:622-633, 2004. 49. Woodley DT, Atha T, Huang Y, Ramin R, Kasahara N, Keene DR, Chen M. Intradermal injection of lentiviral vectors corrects regenerated human dystrophic epidermolysis bullosa skin tissue in vivo. Mol. Ther. 11:318-326, 2004. 50. Woodley DT and Chen M. Epidermolysis bullosa: Then and now. J. Am. Acad. Dermatol. 51:55-57, 2004. 51. Fairley JA, Woodley DT, Chen M, Giudice GJ, Lin MS: A patients with both bullous pemphigoid and epidermolysis bullosa acquisita: A example of intermolecular epitope spreading. J. Am. Acad. Dermatol. 51:117-121, 2004. 52. Li W, Fan J, Chen M, Woodley DT: Mechanisms of human skin cell motility. Histol. Histopathol. 19:1311-1324, 2004. 53. Woodley DT, Chang C, Saddat P, Ram R, Li Z and Chen M: Evidence that anti-type VII collagen antibodies are pathogenic and responsible for the clinical, histological and immunological features of epidermolysis bullosa acquisita, J. Invest. Dermatol. 124:958-564, 2005 54. Li W, Dasgeb B, Phillips T, Li Y, Chen M, Garner W, Woodley DT: Wound-healing perspectives. Dermatol. Clin. 23:181-192, 2005. 55. Fan JF, Guan X, Cheng CF, Cho M, Chen M, Woodley DT, Li W. Protein kinase C clustering at the leading edge and mediating PDGF-enhanced, but not collagen-initiated, dermal fibroblast migration. J. Invest. Dermatol. 126:1233-1243, 2006 56. Bandyopadhyay B, Fan J, Guan S, Li Y, Chen M, Woodley DT, Li W. A "traffic control" role for TGFbeta3: orchestrating dermal and epidermal cell motility during wound healing. J. Cell Biol. 172:1093-1105, 2006 57. Li Y, Chen M, Li W, Woodley DT: Transforming growth factor-alpha elevated in human serum is the major pro-motility factor for human keratinocytes. J. Invest. Dermatol. 2006, in press 58. Woodley DT, Ram R, Doostan A, Bandyopadhyay P, Huang Y, Keene DR and Chen M: Induction of epidermolysis bullosa acquisita in mice by passive transfer of autoantibodies from patients. J. Invest. Dermatol. 126:1323-1330, 2006 59. Chen M, Woodley DT. Fibroblasts as target cells for DEB gene therapy. J. Invest. Dermatol. 126:708-710, 2006